Ameritas Advisory Services LLC Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Ameritas Advisory Services LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 346.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 3,359 shares of the medical equipment provider’s stock after purchasing an additional 2,607 shares during the quarter. Ameritas Advisory Services LLC’s holdings in Intuitive Surgical were worth $1,902,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Ground Swell Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $389,000. Atlantic Union Bankshares Corp increased its holdings in shares of Intuitive Surgical by 3.6% in the fourth quarter. Atlantic Union Bankshares Corp now owns 23,577 shares of the medical equipment provider’s stock worth $13,353,000 after purchasing an additional 818 shares during the last quarter. World Investment Advisors lifted its position in shares of Intuitive Surgical by 27.6% in the fourth quarter. World Investment Advisors now owns 6,888 shares of the medical equipment provider’s stock worth $3,901,000 after buying an additional 1,489 shares in the last quarter. Birchbrook Inc. lifted its position in shares of Intuitive Surgical by 3.7% in the fourth quarter. Birchbrook Inc. now owns 1,590 shares of the medical equipment provider’s stock worth $901,000 after buying an additional 57 shares in the last quarter. Finally, Argos Wealth Advisors LLC bought a new position in Intuitive Surgical during the fourth quarter valued at approximately $551,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Evercore reduced their price objective on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research report on Wednesday, March 11th. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, UBS Group lowered their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Eighteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $581.91.

Intuitive Surgical Stock Up 0.1%

Shares of ISRG opened at $432.27 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $417.74 and a 52-week high of $603.88. The company has a market cap of $153.09 billion, a PE ratio of 52.40, a P/E/G ratio of 3.45 and a beta of 1.51. The business has a fifty day moving average of $466.62 and a 200 day moving average of $515.53.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the firm posted $1.81 earnings per share. The business’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director owned 120 shares of the company’s stock, valued at $55,620. This trade represents a 49.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 5,647 shares of company stock worth $2,760,359 over the last three months. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.